| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 11 Mar 2026 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | +9,500 | +7308% | $146.03* | 9,630 | 11 Mar 2026 | Direct | F1 | |
| transaction | UTHR | Common Stock | Sale | $191,566 | -360 | -3.7% | $532.13 | 9,270 | 11 Mar 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $128,032 | -240 | -2.6% | $533.47 | 9,030 | 11 Mar 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $441,512 | -824 | -9.1% | $535.82 | 8,206 | 11 Mar 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $652,390 | -1,215 | -15% | $536.95 | 6,991 | 11 Mar 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $595,040 | -1,106 | -16% | $538.01 | 5,885 | 11 Mar 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $590,121 | -1,095 | -19% | $538.92 | 4,790 | 11 Mar 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $453,658 | -840 | -18% | $540.07 | 3,950 | 11 Mar 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $509,664 | -942 | -24% | $541.04 | 3,008 | 11 Mar 2026 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $638,631 | -1,178 | -39% | $542.13 | 1,830 | 11 Mar 2026 | Direct | F1, F10 |
| transaction | UTHR | Common Stock | Sale | $130,328 | -240 | -13% | $543.04 | 1,590 | 11 Mar 2026 | Direct | F1, F11 |
| transaction | UTHR | Common Stock | Sale | $631,276 | -1,160 | -73% | $544.20 | 430 | 11 Mar 2026 | Direct | F1, F12 |
| transaction | UTHR | Common Stock | Sale | $163,428 | -300 | -70% | $544.76 | 130 | 11 Mar 2026 | Direct | F1, F13 |
| holding | UTHR | Common Stock | 166 | 11 Mar 2026 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 11 Mar 2026 | by Trust | F14 | |||||
| holding | UTHR | Common Stock | 258,117 | 11 Mar 2026 | by Trust | F15 | |||||
| holding | UTHR | Common Stock | 45,596 | 11 Mar 2026 | by Trust | F16 | |||||
| holding | UTHR | Common Stock | 10,962 | 11 Mar 2026 | by Trust | F17 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | -9,500 | -5.5% | $0.000000* | 164,000 | 11 Mar 2026 | Common Stock | 9,500 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. |
| F2 | This transaction was executed in multiple trades at prices ranging from $531.90 to $532.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $533.04 to $533.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $535.42 to $536.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $536.44 to $537.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $537.46 to $538.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $538.46 to $539.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $539.52 to $540.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $540.56 to $541.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $541.56 to $542.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F11 | This transaction was executed in multiple trades at prices ranging from $542.64 to $543.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F12 | This transaction was executed in multiple trades at prices ranging from $543.66 to $544.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F13 | This transaction was executed in multiple trades at prices ranging from $544.68 to $544.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F14 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F15 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F16 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F17 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |